Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Newer Targets
Stanford researchers program cancer-fighting cells to resist exhaustion, attack solid tumors…
Newer Targets
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach…
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
FDA Committee Votes 6-6 on Durect’s Non-Opioid Pain Drug
Approval
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes…
Clinical
FDA advisory panel split on whether to approve Durect’s Posimir for…
Approval
Breast cancer patients to have further NICE-approved drug combination option on…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for…
Deals
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy…
Commercial
US judge hacks $8-billion damages verdict against Johnson & Johnson in…
Deals
JPM Day 3: High Prices in San Francisco Are a Problem,…
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
Ipsen Appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer
Biospace News
-
January 14, 2020
Lay off/Spin-off/Appointments
Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer
Lay off/Spin-off/Appointments
HUYA Bioscience International Appoints Meiji Seika Pharma as Exclusive Distributor For HBI-8000 in Japan and Other Asian Countries
Lay off/Spin-off/Appointments
Aeromics, Inc. Appoints Joseph Schindler, M.D. as Chief Medical Officer
Lay off/Spin-off/Appointments
Alzheon Announces Appointment of Peter N. Laivins as Head of Commercial Strategy and Planning
Lay off/Spin-off/Appointments
Alzheon Announces Appointments of Noel Dunn, Jordan Heller, and Diane Jorkasky,...
Biospace News
-
January 7, 2020
0
Lay off/Spin-off/Appointments
Oncopeptides Strengthens its Regulatory Function by Appointing Karin Eklund Vanderpol as...
Biospace News
-
January 7, 2020
0
Lay off/Spin-off/Appointments
Biocon Biologics Appoints M.B. Chinappa as Chief Financial Officer
Biospace News
-
January 6, 2020
0
Lay off/Spin-off/Appointments
FerGene Appoints David Meek President and Chief Executive Officer
Biospace News
-
December 18, 2019
0
Lay off/Spin-off/Appointments
RAPT Therapeutics Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biospace News
-
December 10, 2019
0
1
2
3
...
32
Page 1 of 32
- Advertisement -
MOST POPULAR
Clene Nanomedicine Announces First Patient Dosed in the REPAIR-MS Clinical Trial...
January 9, 2020
Immatics Announces Clinical Trial Collaboration in Immunotherapy for Solid Cancers
February 27, 2019
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
May 13, 2019
LEO Science & Tech Hub and Epicore Biosystems Announce Second Phase...
November 7, 2019
Load more
HOT NEWS
Commercial
Alkermes Plc Reports Financial Results for the Year Ended Dec. 31,...
Others
Ethicann Pharmaceuticals Forms Partnership with Ilera Therapeutics for the Development and...
Deals
Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize...
Others
Scottish Medicines Consortium December 2019 decisions news release
